Get the Stockscreener App
18.01
1.32%
-0.24
After Hours:
17.97
-0.04
-0.22%
Eton Pharmaceuticals Inc stock is traded at $18.01, with a volume of 161.08K.
It is down -1.32% in the last 24 hours and down -17.12% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$18.25
Open:
$18.14
24h Volume:
161.08K
Relative Volume:
0.55
Market Cap:
$482.98M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-69.27
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
-2.44%
1M Performance:
-17.12%
6M Performance:
+6.88%
1Y Performance:
+112.63%
1-Day Range:
$17.70
$18.53
1-Week Range:
$17.70
$18.92
52-Week Range:
$8.24
$23.00
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
18.01 | 489.42M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Eton Pharmaceuticals (ETON) to Release Quarterly Earnings on Thursday - MarketBeat
Is Eton Pharmaceuticals Inc. stock bottoming out2025 Performance Recap & Verified Trade Idea Suggestions - newser.com
Is Eton Pharmaceuticals Inc. a candidate for recovery play2025 Market Trends & High Accuracy Buy Signal Tips - newser.com
Can Eton Pharmaceuticals Inc. hit a new high this monthJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
How Eton Pharmaceuticals Inc. stock compares to market leadersTrade Analysis Report & Reliable Entry Point Trade Alerts - newser.com
Will Eton Pharmaceuticals Inc. stock see insider buyingWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - newser.com
Sector ETF performance correlation with Eton Pharmaceuticals Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
Is a relief rally coming for Eton Pharmaceuticals Inc. holdersJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
Street Watch: Will Eton Pharmaceuticals Inc. stock deliver shareholder value2025 Geopolitical Influence & Verified Short-Term Plans - Fundação Cultural do Pará
Institutional investors own a significant stake of 44% in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Yahoo Finance
Is Eton Pharmaceuticals Inc. stock attractive for retirement portfoliosJuly 2025 Breakouts & Real-Time Market Trend Scan - newser.com
Eton Pharmaceuticals (NASDAQ:ETON) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Eton Pharmaceuticals Inc Stock (ETON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Gruber James R. | Chief Financial Officer |
Aug 20 '25 |
Sale |
16.02 |
2,631 |
42,149 |
204,753 |
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):